Raman Spectroscopy for Rapid Evaluation of Surgical Margins during Breast Cancer Lumpectomy

Abstract Failure to precisely distinguish malignant from healthy tissue has severe implications for breast cancer surgical outcomes. Clinical prognoses depend on precisely distinguishing healthy from malignant tissue during surgery. Laser Raman spectroscopy (LRS) has been previously shown to differe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Willie C. Zúñiga, Veronica Jones, Sarah M. Anderson, Alex Echevarria, Nathaniel L. Miller, Connor Stashko, Daniel Schmolze, Philip D. Cha, Ragini Kothari, Yuman Fong, Michael C. Storrie-Lombardi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6b11c7736f184d34bbc3a967e226cd9e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6b11c7736f184d34bbc3a967e226cd9e
record_format dspace
spelling oai:doaj.org-article:6b11c7736f184d34bbc3a967e226cd9e2021-12-02T15:09:21ZRaman Spectroscopy for Rapid Evaluation of Surgical Margins during Breast Cancer Lumpectomy10.1038/s41598-019-51112-02045-2322https://doaj.org/article/6b11c7736f184d34bbc3a967e226cd9e2019-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-51112-0https://doaj.org/toc/2045-2322Abstract Failure to precisely distinguish malignant from healthy tissue has severe implications for breast cancer surgical outcomes. Clinical prognoses depend on precisely distinguishing healthy from malignant tissue during surgery. Laser Raman spectroscopy (LRS) has been previously shown to differentiate benign from malignant tissue in real time. However, the cost, assembly effort, and technical expertise needed for construction and implementation of the technique have prohibited widespread adoption. Recently, Raman spectrometers have been developed for non-medical uses and have become commercially available and affordable. Here we demonstrate that this current generation of Raman spectrometers can readily identify cancer in breast surgical specimens. We evaluated two commercially available, portable, near-infrared Raman systems operating at excitation wavelengths of either 785 nm or 1064 nm, collecting a total of 164 Raman spectra from cancerous, benign, and transitional regions of resected breast tissue from six patients undergoing mastectomy. The spectra were classified using standard multivariate statistical techniques. We identified a minimal set of spectral bands sufficient to reliably distinguish between healthy and malignant tissue using either the 1064 nm or 785 nm system. Our results indicate that current generation Raman spectrometers can be used as a rapid diagnostic technique distinguishing benign from malignant tissue during surgery.Willie C. ZúñigaVeronica JonesSarah M. AndersonAlex EchevarriaNathaniel L. MillerConnor StashkoDaniel SchmolzePhilip D. ChaRagini KothariYuman FongMichael C. Storrie-LombardiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-16 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Willie C. Zúñiga
Veronica Jones
Sarah M. Anderson
Alex Echevarria
Nathaniel L. Miller
Connor Stashko
Daniel Schmolze
Philip D. Cha
Ragini Kothari
Yuman Fong
Michael C. Storrie-Lombardi
Raman Spectroscopy for Rapid Evaluation of Surgical Margins during Breast Cancer Lumpectomy
description Abstract Failure to precisely distinguish malignant from healthy tissue has severe implications for breast cancer surgical outcomes. Clinical prognoses depend on precisely distinguishing healthy from malignant tissue during surgery. Laser Raman spectroscopy (LRS) has been previously shown to differentiate benign from malignant tissue in real time. However, the cost, assembly effort, and technical expertise needed for construction and implementation of the technique have prohibited widespread adoption. Recently, Raman spectrometers have been developed for non-medical uses and have become commercially available and affordable. Here we demonstrate that this current generation of Raman spectrometers can readily identify cancer in breast surgical specimens. We evaluated two commercially available, portable, near-infrared Raman systems operating at excitation wavelengths of either 785 nm or 1064 nm, collecting a total of 164 Raman spectra from cancerous, benign, and transitional regions of resected breast tissue from six patients undergoing mastectomy. The spectra were classified using standard multivariate statistical techniques. We identified a minimal set of spectral bands sufficient to reliably distinguish between healthy and malignant tissue using either the 1064 nm or 785 nm system. Our results indicate that current generation Raman spectrometers can be used as a rapid diagnostic technique distinguishing benign from malignant tissue during surgery.
format article
author Willie C. Zúñiga
Veronica Jones
Sarah M. Anderson
Alex Echevarria
Nathaniel L. Miller
Connor Stashko
Daniel Schmolze
Philip D. Cha
Ragini Kothari
Yuman Fong
Michael C. Storrie-Lombardi
author_facet Willie C. Zúñiga
Veronica Jones
Sarah M. Anderson
Alex Echevarria
Nathaniel L. Miller
Connor Stashko
Daniel Schmolze
Philip D. Cha
Ragini Kothari
Yuman Fong
Michael C. Storrie-Lombardi
author_sort Willie C. Zúñiga
title Raman Spectroscopy for Rapid Evaluation of Surgical Margins during Breast Cancer Lumpectomy
title_short Raman Spectroscopy for Rapid Evaluation of Surgical Margins during Breast Cancer Lumpectomy
title_full Raman Spectroscopy for Rapid Evaluation of Surgical Margins during Breast Cancer Lumpectomy
title_fullStr Raman Spectroscopy for Rapid Evaluation of Surgical Margins during Breast Cancer Lumpectomy
title_full_unstemmed Raman Spectroscopy for Rapid Evaluation of Surgical Margins during Breast Cancer Lumpectomy
title_sort raman spectroscopy for rapid evaluation of surgical margins during breast cancer lumpectomy
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/6b11c7736f184d34bbc3a967e226cd9e
work_keys_str_mv AT willieczuniga ramanspectroscopyforrapidevaluationofsurgicalmarginsduringbreastcancerlumpectomy
AT veronicajones ramanspectroscopyforrapidevaluationofsurgicalmarginsduringbreastcancerlumpectomy
AT sarahmanderson ramanspectroscopyforrapidevaluationofsurgicalmarginsduringbreastcancerlumpectomy
AT alexechevarria ramanspectroscopyforrapidevaluationofsurgicalmarginsduringbreastcancerlumpectomy
AT nathaniellmiller ramanspectroscopyforrapidevaluationofsurgicalmarginsduringbreastcancerlumpectomy
AT connorstashko ramanspectroscopyforrapidevaluationofsurgicalmarginsduringbreastcancerlumpectomy
AT danielschmolze ramanspectroscopyforrapidevaluationofsurgicalmarginsduringbreastcancerlumpectomy
AT philipdcha ramanspectroscopyforrapidevaluationofsurgicalmarginsduringbreastcancerlumpectomy
AT raginikothari ramanspectroscopyforrapidevaluationofsurgicalmarginsduringbreastcancerlumpectomy
AT yumanfong ramanspectroscopyforrapidevaluationofsurgicalmarginsduringbreastcancerlumpectomy
AT michaelcstorrielombardi ramanspectroscopyforrapidevaluationofsurgicalmarginsduringbreastcancerlumpectomy
_version_ 1718387819275091968